A Thermodynamic study on the interaction of bovine calf thymus DNA with new designed Pd(II) complex (Ethylendiamine-8-hydroxyquinolinato Palladium(II) chloride) was studied by using isothermal titration calorimetry (ITC) at 27 o C in Tris buffer solution at pH = 7.5. The enthalpies of Pd(II) complex + DNA interaction are reported and analysed in terms of the new solvation theory. It was indicated that there are three identical and non-cooperative sites for Pd(II) complex. The binding of a Pd(II) complex is endothermic with association equilibrium constants of 428.03 mM -1 at 27 o C. The binding of Pd(II) complex can cause some changes in the stability of the DNA at low and high Pd(II) complex concentrations. Our results suggested that this complex might interact with DNA as an intercalator, thus interfering with DNA replication and cell proliferation.
Introduction
DNA plays an important role in the life process, because it bears heritage information and instructs the biological synthesis of proteins and enzymes through the replication and transcription of genetic information in living cells. 1 The main target of anti-tumor chemotherapies is DNA.
1,2 Alteration of DNA structure affects its synthesis and function which usually leads to disruption of cell proliferation and can eventually elicit cell death via apoptosis. These effects are currently being exploited to develop novel biologically active drugs with potential applications as anti-proliferative therapies, e.g. ligands that will form ternary complexes with DNA and the enzyme (s) topoisomerase. [3] [4] [5] Several experiments have also demonstrated that DNA is the primary intracellular target of anticancer drugs due to the interaction between small molecules and DNA, which can cause DNA damage in cancer cells, blocking the division of cancer cells and resulting in cell death. [4] [5] [6] In addition, the apoptosis can also cause the cell death. 7 The ability of small molecules to interfere with transcription and DNA replication makes it a major target for drug interaction studies. 7 Transition metal complexes have attracted considerable attention as catalytic systems for use in the oxidation of organic compounds, 8 probes in electron-transfer reactions involving metallo-proteins, and intercalators with DNA. 3, 9 During recent years, the interest for metal complexes containing planar extended polyaromatic ligands has increased tremendously, mainly for their usage as probes capable to utilize the nucleic acid structures 1,2 and as DNA-molecular light switches. 10 There are several types of sites in the DNA molecule where binding of metal complexes can occur: (I) between two base pairs (intercalation), (II) in the minor groove, (III) in the major groove, and (IV) on the outside of the helix. 11 Among these complexes, the role of the Pt(II) and Pd(II) complexes is crucial since they can bind to DNA covalently as well as noncovalently. Several reports have shown that palladium complexes are expected to have lower kidney toxicity than cisplatin due to the inability of proteins in the kidney tubules to replace the tightly bound chelate ligands of Pd(II) with sulfydril groups. [12] [13] [14] [15] Concerning the noncovalent interactions between transition-metal complexes and DNA, they can occur by intercalation, groove binding, or external electrostatic binding. [10] [11] Many anticancer drugs are known to interact with DNA to exert their biological activities. Generally, DNA-acting anticancer drugs can be classified into three categories. Drugs of the first category form covalent linkages with DNA while drugs of the second category form noncovalent complexes with DNA by either intercalation or groove-binding. Drugs of the final category cause DNA backbone cleavages. 8 A search for new, low-molecular weight ligands which can specifically bind to DNA has been conducted for many years in the hope that new therapeutics could selectively modulate aberrant gene expression. 1 Since design of new drugs that directly interacted with DNA is very important, in present study, we have investigated the effect of the new designed Pd(II) complex (Ethylendiamine 8-hydroxyquinolinato Palladium(II) chloride) (Scheme 1) on the stability of the calf thymus DNA, in addition to some investigations on the binding parameters of complex to the DNA has been considered. Information obtained from these studies will be helpful to understand the mechanisms of the interaction between the metal anticancer complexes and nucleic acids.
Materials and Method
Calf thymus DNA was obtained from Sigma. For the synthesis of ethylenediamine-8-hydroxyquinolinatopalladium(II) chloride, Pd(II) complex (Scheme 1), material required: 8-hydroxyquinolin, ethylenediamine, potassium tetrachloropalladate(II), sodium bicarbonate and sodium chloride were purchased from Aldrich (U. K). The first stage in this synthesis is the preparation of ethylenediamine palladium(II) dichloride [Pd(en)Cl 2 ], from which the titled compound is obtained. Place 1 H NMR (500 MHz, DMSO-d6, ppm): protons of ethylenediamine moiety resonate at 2.6 (s, 4H, C2H4), 5.6 (s, 2H, NH2), and 5.8 (s, 2H, NH2) and the protons of quinoline moiety resonate at 6.8 (doublet), 7.07 (doublet), 7.42 (triplet), 7.60 (quarter), 8 .38 (doublet) and 8.56 (doublet). Electronic absorption spectrum of the Pd(II) complex shows two bands at 260 and 375 nm which are tentatively be assigned to the transition of n → δ* of phenolic C-O and π → π* of C = N aromatic ring respectively.
The buffer solution used in the experiments was 50 mM Tris, pH = 7.5, which was obtained from Merck. All other materials and reagents were of analytical grade.
The isothermal titration calorimetric experiments were carried out on a VP-ITC ultra sensitive titration calorimeter (MicroCal, LLC, Northampton, MA). The microcalorimeter consists of a reference cell and a sample cell of 1.8 mL in volume, with both cells insulated by an adiabatic shield. All solutions were thoroughly degassed before use by stirring under vacuum. The sample cell was loaded with DNA solution (120 µM) and the reference cell contained buffer solution. The solution in the cell was stirred at 307 rpm by the syringe (equipped with micro propeller) filled with Pd solution (2 mM) to ensure rapid mixing. Injections were started after baseline stability had been achieved. The titration of DNA with Pd solution involved 30 consecutive injections of the ligand solution, the first injection was 5 µL and the remaining ones were 10 µL. In all cases, each injection was done in 6 s at 3-min intervals. To correct the thermal effects due to Pd dilution, control experiments were done in which identical aliquots were injected into the buffer solution with the exception of DNA. In the ITC experiments, the enthalpy changes associated with processes occurring at a constant temperature are measured. The measurements were performed at a constant temperature of 27.0 ± 0.02 o C and the temperature was controlled using a Poly-Science water bath.
Results and Discussion
It has been shown previously [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] that the enthalpies of interactions of biopolymers with ligands (DNA + Pd(II) complex in this case) in the aqueous solvent (Pd(II) complex + water in the present case) mixtures, can be reproduced via the following equation. 
[Pd(II) complex]T is the total concentration of the Pd(II) complex and [Pd(II) complex]max is the maximum concentration of the Pd(II) complex upon saturation of all DNA. L A and L B are the relative contributions of unbounded and bounded Pd(II) complex to the enthalpies of dilution with the exclusion of DNA and can be calculated from the enthalpies of dilution of Pd(II) complex in buffer as follows:
The enthalpies of Pd(II) complex + DNA interactions, Q , were fitted to Eq. 1 over the whole Pd(II) complex compositions. In the fitting procedure, p parameter varied in the course of an iterative process until the best fit between experimental and calculated data was approached (Fig. 1) . Table 2 . The agreement between the calculated and experimental results (Fig. 1) is striking, and gives considerable support to the use of Eq. 1. Φ is the fraction of DNA molecule undergoing complexation with Pd(II) complex which can be expressed as follows:
Qmax represents the heat value upon saturation of all DNA. The appearance equilibrium constant values, Ka, as a function of free concentration of Pd(II) complex, [Pd(II) complex]F, can be calculated as follows:
The Gibbs free energies as a function of Pd(II) complex concentrations can be obtained as follows:
Gibbs energies, ∆G, at different temperatures calculated from Eq. 7 have shown graphically in Fig. 2 . ∆S values were calculated using ∆G values at different temperatures and have shown in Fig. 3 . Consider a solution containing a ligand (Pd(II) complex) and a macromolecule (DNAg) that contains "g" sites capable of binding the ligand. If the multiple binding sites on a macromolecule are identical and independent, the ligand binding sites can be reproduced by a model system of monovalent molecules (DNAg → gDNA) with the same set of dissociation equilibrium constant, Kd, values. Thus, the reaction under consideration can be written: 
Substitution of free concentrations of all these components in Eq. 8 gives:
The value of 1 -α as the fraction of occupied binding sites on the biomacromolecule:
where q represents the heat value at a certain L0 and Qmax represents the heat value upon saturation of all biomacromolecules. The combination of Eqs.13 and 14 yields:
Where Therefore, the plot of versus should be a linear plot with a slope of and a verticalintercept of .
The linearity of the plot has been examined by different estimated values for Q max to reach the best value for the correlation coefficient. The best linear plot with the correlation coefficient value ( ) show that there is strong interaction between Pd(II) complex and DNA, which is in agreement with the above interpretation. Also, other reports have revealed that small organic compounds and transition metal complexes could bind noncovalently (including as intercalators and groove binders) to nucleic acids. These interactions have been shown to disrupt the replication and/or transcription culminating in a cellular death. 27 Intercalators, by definition, bind into DNA by intercalating the flat aromatic ring between the base pairs of the DNA duplex. 28 An intercalator makes contact with two base-pairs whereas a groove binder can span many more, making interactions with several reactive sites along DNA grooves, e.g. phosphate groups, electron acceptors and donors, hydrophobic sites, and acidic hydrogen's. 3 Since the new synthesized Pd(II) complex is a planar system, then, the planar moieties of this complex might be inserted between the DNA base-pairs, parallel to their aromatic rings and perpendicular to the helical axis. As a consequence, this complex might interact with DNA as an intercalator, thus interfering with DNA replication and cell proliferation.
Conclusion
The enthalpies of Pd(II) complex + DNA interaction were fitted to Eq. 1 over the whole Pd(II) complex compositions. In the procedure, the only adjustable parameter (p) was changed until the best agreement between the experimental and calculated data was approached (Fig. 1) . The optimized θ δ A and θ δ B values are recovered from the coefficients of the second and third terms of Eq. 1. The agreement between the calculated and experimental results (Fig. 1) is striking, and gives considerable support to the use of Eq. 1. p = 1 indicates that the binding of Pd(II) complex with DNA is non-cooperative. A suitable value for Qmax to obtain a linear plot of  (∆Q/Qmax)M0 vs. (∆Q/Q)L0 indicates that there are a set of three identical and non-interacting binding sites on DNA for Pd(II) complex.
